ATE392218T1 - Stabilisierte 99mtc zusammensetzung - Google Patents

Stabilisierte 99mtc zusammensetzung

Info

Publication number
ATE392218T1
ATE392218T1 AT05794253T AT05794253T ATE392218T1 AT E392218 T1 ATE392218 T1 AT E392218T1 AT 05794253 T AT05794253 T AT 05794253T AT 05794253 T AT05794253 T AT 05794253T AT E392218 T1 ATE392218 T1 AT E392218T1
Authority
AT
Austria
Prior art keywords
99mtc
tetrofosmin
stabilized
composition
lyophilised
Prior art date
Application number
AT05794253T
Other languages
English (en)
Inventor
Grethe Martinussen
Gry Stensrud
Ole Hjelstuen
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Application granted granted Critical
Publication of ATE392218T1 publication Critical patent/ATE392218T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Lock And Its Accessories (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Devices For Supply Of Signal Current (AREA)
  • Noodles (AREA)
  • Train Traffic Observation, Control, And Security (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05794253T 2004-12-15 2005-10-14 Stabilisierte 99mtc zusammensetzung ATE392218T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0427392.6A GB0427392D0 (en) 2004-12-15 2004-12-15 Stabilised 99mTc compositions

Publications (1)

Publication Number Publication Date
ATE392218T1 true ATE392218T1 (de) 2008-05-15

Family

ID=34090037

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05794253T ATE392218T1 (de) 2004-12-15 2005-10-14 Stabilisierte 99mtc zusammensetzung

Country Status (17)

Country Link
US (1) US9694092B2 (de)
EP (1) EP1824525B1 (de)
JP (1) JP5064236B2 (de)
KR (1) KR101297523B1 (de)
CN (2) CN101107017A (de)
AT (1) ATE392218T1 (de)
AU (1) AU2005315503B2 (de)
BR (1) BRPI0518636B8 (de)
CA (1) CA2590620C (de)
DE (1) DE602005006157T2 (de)
ES (1) ES2306219T3 (de)
GB (1) GB0427392D0 (de)
MX (1) MX2007007223A (de)
NO (1) NO340538B1 (de)
PL (1) PL1824525T3 (de)
RU (1) RU2403067C2 (de)
WO (1) WO2006064175A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007148088A2 (en) * 2006-06-21 2007-12-27 Ge Healthcare Limited Radiopharmaceutical products
WO2008056481A1 (fr) * 2006-11-09 2008-05-15 Nihon Medi-Physics Co., Ltd. Agent d'imagerie de diagnostic radioactif
GB0718386D0 (en) * 2007-09-21 2007-10-31 Ge Healthcare As Improved radiopharmaceutical formulation
RU2463075C1 (ru) * 2011-07-01 2012-10-10 Российская Федерация, От Имени Которой Выступает Министерство Образования И Науки Российской Федерации СПОСОБ ПОЛУЧЕНИЯ МЕЧЕННОГО ТЕХНЕЦИЕМ-99m НАНОКОЛЛОИДА
RU2512595C1 (ru) * 2013-01-09 2014-04-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт онкологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИ онкологии" СО РАМН) СПОСОБ ПОЛУЧЕНИЯ РЕАГЕНТА ДЛЯ ПРИГОТОВЛЕНИЯ МЕЧЕННОГО ТЕХНЕЦИЕМ 99-m НАНОКОЛЛОИДА НА ОСНОВЕ ГАММА-ОКСИДА АЛЮМИНИЯ
RU2543654C1 (ru) * 2013-11-29 2015-03-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский политехнический университет" СПОСОБ ПОЛУЧЕНИЯ МЕЧЕННОГО ТЕХНЕЦИЕМ-99m НАНОКОЛЛОИДА
EP2899195A1 (de) 2014-01-28 2015-07-29 ROTOP Pharmaka AG Stabilisierte Form von Tetrofosmin und seine Verwendung
EP3183008B1 (de) 2015-09-30 2019-06-26 Duke University Ascorbatformulierungen und verfahren zur verwendung als kontrastmittel
IT201600101875A1 (it) * 2016-10-11 2018-04-11 Advanced Accelerator Applications Int S A Composizioni liofilizzate comprendenti rhAnnexin V-128, processo per la loro preparazione e loro uso per la preparazione di formulazioni contenenti 99mTc-rhAnnexin V-128
EP3592735B1 (de) * 2017-03-08 2024-03-20 Jubilant Generics Limited (Formerly a Division of Jubilant Life Sciences Limited) Verbessertes verfahren zur herstellung von tetrofosmin oder eines säureadditionssalzes davon
JP2021504296A (ja) * 2017-11-23 2021-02-15 ジュビラント・ジェネリックス・リミテッド テトロホスミン及びその薬学的に許容できる塩を含む医薬組成物
EP3860576A4 (de) * 2018-10-06 2022-07-20 Jubilant Generics Limited Pharmazeutische zusammensetzungen von schwefelkolloid und verfahren dafür

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761944B (en) 1975-04-30 1977-03-30 Procter & Gamble Stable radiographic scanning agents
JPS5750928A (en) 1980-09-13 1982-03-25 Nippon Mejifuijitsukusu Kk Diagnostic agent for scanning bone
JPS5896031A (ja) * 1981-12-03 1983-06-07 Nippon Mejifuijitsukusu Kk 放射性診断剤およびその製造用組成物
GB8808414D0 (en) 1988-04-11 1988-05-11 Amersham Int Plc Ligands & cationic complexes thereof with technetium-99m
JP2860157B2 (ja) 1990-10-31 1999-02-24 日本メジフィジックス株式会社 腎機能測定用の既放射能標識テクネチウムキレート注射剤の製造方法
US5300280A (en) * 1992-02-14 1994-04-05 Mallinckrodt Medical, Inc. Stabilized radiopharmaceutical kits
JP4343473B2 (ja) 1999-06-21 2009-10-14 日本メジフィジックス株式会社 血漿蛋白質に結合親和性を有する薬剤の投与方法並びに当該投与方法に用いられる製剤
CN1184225C (zh) * 2000-06-28 2005-01-12 北京师范大学 一种替曲膦季鏻盐及其制法和二步法替曲膦药盒及其应用
GB0031592D0 (en) * 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
EP1365813A4 (de) * 2001-02-26 2006-03-22 Bristol Myers Squibb Pharma Co Analoge der ascorbinsäure für metalloradiopharmaka

Also Published As

Publication number Publication date
ES2306219T3 (es) 2008-11-01
NO20073158L (no) 2007-07-04
KR101297523B1 (ko) 2013-08-16
CA2590620C (en) 2012-12-04
US9694092B2 (en) 2017-07-04
RU2007120467A (ru) 2009-01-27
BRPI0518636A2 (pt) 2008-12-02
DE602005006157D1 (de) 2008-05-29
WO2006064175A1 (en) 2006-06-22
NO340538B1 (no) 2017-05-02
CA2590620A1 (en) 2006-06-22
RU2403067C2 (ru) 2010-11-10
AU2005315503A1 (en) 2006-06-22
GB0427392D0 (en) 2005-01-19
EP1824525B1 (de) 2008-04-16
PL1824525T3 (pl) 2008-11-28
DE602005006157T2 (de) 2009-05-28
MX2007007223A (es) 2007-08-14
US20110008252A9 (en) 2011-01-13
BRPI0518636B8 (pt) 2021-07-27
JP5064236B2 (ja) 2012-10-31
EP1824525A1 (de) 2007-08-29
BRPI0518636B1 (pt) 2016-12-13
AU2005315503B2 (en) 2011-06-02
KR20070089156A (ko) 2007-08-30
CN101107017A (zh) 2008-01-16
CN103028123A (zh) 2013-04-10
US20090311178A1 (en) 2009-12-17
JP2008524178A (ja) 2008-07-10

Similar Documents

Publication Publication Date Title
ATE392218T1 (de) Stabilisierte 99mtc zusammensetzung
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
TNSN07341A1 (en) Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
CY1115825T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν λεβετιρακεταμη και διαδικασια παρασκευης τους
TW200800967A (en) Benzimidazole thiophene compounds
TW200738659A (en) Novel compounds
CL2009000906A1 (es) Compuestos derivados de 4-imidazolil y 4-triazolil de 2-(6-(4-cicloalquilpiperazin-1-il)pirimidin-4-il)-1h-pirazol-3(2h)ona inhibidores de hif-prolil-4-hidroxilasas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de enfermedades cardiovasculares, renales y hematologicas.
DE602006020295D1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
NO20074737L (no) Isokinolinforbindelser og fremgangsmater for anvendelse derav
TW200640857A (en) Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
MX2009011493A (es) Complejo de excipiente farmaceutico.
WO2012168885A3 (en) Bisacodyl and its analogues as drugs for use in the treatment of cancer
WO2006088903A3 (en) Pyrazole compounds
UA87312C2 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
WO2009013358A3 (en) Polysaccharides grafted by polyamines for the preparation of radiopharmaceutical compositions
HRP20080422T3 (en) Satraplatin for treating resistant or refractory tumors
TW200800993A (en) Organic compounds
UA92180C2 (en) Benzimidazole thiophene compounds as plk inhibitors
MX2008001412A (es) Derivados de fenilpiridina, su obtencion y su utilizacion como agentes farmaceuticos.
NO20085285L (no) 2-alkosy-3,4,5-tnhydroksyalkylamidbenzazepiner, deres fremstilling og bruk samt preparater inneholdende disse
EA200870566A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламидобензотиазепины, их получение, композиции, содержащие их, и применение
WO2018222169A3 (en) VANADIUM INSULIN MIMETICS, PREPARATION METHODS AND METHODS FOR TREATING DIABETES
GB0327186D0 (en) Organic compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties